Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelomonocytic, Acute × Alemtuzumab × 1 year × Clear all

Sponsor

Conditions

Wilms Tumor 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Pseudomyxoma Peritonei 1 Neuroblastoma 1 Neoplasms, Germ Cell and Embryonal 1 Melanoma 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Kidney Transplantation 1 Digestive System Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Burkitt Lymphoma 1 Adenocarcinoma, Clear Cell 1

Interventions

Cytarabine 4 Idarubicin 3 Injections 2 Gemtuzumab 2 Filgrastim 2 Decitabine 2 veliparib 1 fludarabine phosphate 1 aldesleukin 1 Whole-Body Irradiation 1 Temozolomide 1 Sirolimus 1 Peripheral Blood Stem Cell Transplantation 1 Granulocyte Colony-Stimulating Factor 1 Etoposide 1 Daunorubicin 1 CPX-351 1 Busulfan 1 Bone Marrow Transplantation 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡